Skip to main content
Top
Published in: Abdominal Radiology 1/2009

01-01-2009

Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations

Authors: Elena Manak, Susanne Merkel, Peter Klein, Thomas Papadopoulos, Werner A. Bautz, Ulrich Baum

Published in: Abdominal Radiology | Issue 1/2009

Login to get access

Abstract

The purpose was to assess capabilities of the multidetector-row computed tomography (MDCT) with multiplanar reformations (MPR) for predicting of pancreatic adenocarcinoma resectability. Forty-eight patients deemed to have resectable pancreatic adenocarcinoma after assessment using biphasic MDCT with MPRs underwent surgery for potential tumor resection. Imaging findings were retrospectively evaluated for tumor resectability and correlated with surgical and pathological results. Curative resection was successful in 44 of 48 patients. The positive predictive value for tumor resectability made up 91% with four false-negative results. The reasons for unresectability were venous involvement (1), small liver metastases (2) and peritoneal involvement associated with small metastases to lymph nodes (1). MDCT yielded a negative predictive value of 99% (286 of 288 vessels) for detection of vascular invasion. Our results indicate the tendency towards improved prediction of resectability using MDCT compared to single-detector CT.
Literature
1.
go back to reference Freeny PC, Marks WM, Ryan JA, et al. (1988) Pancreatic ductal adenacarcinoma: diagnosis and staging with dynamic CT. Radiology 166:125–133PubMed Freeny PC, Marks WM, Ryan JA, et al. (1988) Pancreatic ductal adenacarcinoma: diagnosis and staging with dynamic CT. Radiology 166:125–133PubMed
2.
go back to reference Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385PubMed
3.
go back to reference Valls C, Andia E, Sanchez A, et al. (2002) Dual-phase helical CT of pancreatic adenocarcinomaá: assessment of resectability before surgery. AJR 178:821–826PubMed Valls C, Andia E, Sanchez A, et al. (2002) Dual-phase helical CT of pancreatic adenocarcinomaá: assessment of resectability before surgery. AJR 178:821–826PubMed
4.
go back to reference Diehl SJ, Lehmann KJ, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206(2):373–378PubMed Diehl SJ, Lehmann KJ, Sadick M, et al. (1998) Pancreatic cancer: value of dual-phase helical CT in assessing resectability. Radiology 206(2):373–378PubMed
5.
go back to reference Kalpa MK, Maher MM, Sahani DV, et al. (2002) Current status of imaging in pancreatic diseases. J Comput Assist Tomogr 26:661–675CrossRef Kalpa MK, Maher MM, Sahani DV, et al. (2002) Current status of imaging in pancreatic diseases. J Comput Assist Tomogr 26:661–675CrossRef
6.
go back to reference Bipat S, Phoa SS, van Delden OM, et al. (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a metaanalysis. J Comput Assist Tomogr 29(4):438–445PubMedCrossRef Bipat S, Phoa SS, van Delden OM, et al. (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a metaanalysis. J Comput Assist Tomogr 29(4):438–445PubMedCrossRef
7.
go back to reference Baum U, Lell M, Nomayr A, et al. (1999) Multiplanar spiral CT in the diagnosis of pancreatic tumors. Radiologe 39a:958–964CrossRef Baum U, Lell M, Nomayr A, et al. (1999) Multiplanar spiral CT in the diagnosis of pancreatic tumors. Radiologe 39a:958–964CrossRef
8.
go back to reference Fishman EK, Horton KM, Urban BA (2000) Multidetector CT angiography in the evaluation of pancreatic carcinoma: preliminary observations. J Comput Assist Tomogr 24:849–853PubMedCrossRef Fishman EK, Horton KM, Urban BA (2000) Multidetector CT angiography in the evaluation of pancreatic carcinoma: preliminary observations. J Comput Assist Tomogr 24:849–853PubMedCrossRef
9.
go back to reference Fenchel S, Boll DT, Fleiter TR, et al. (2003) Multislice helical CT of the pancreas and spleen. Eur J Radiol 45 Suppl 1:59–72CrossRef Fenchel S, Boll DT, Fleiter TR, et al. (2003) Multislice helical CT of the pancreas and spleen. Eur J Radiol 45 Suppl 1:59–72CrossRef
10.
go back to reference Nino-Murcia M, Tamm EP, Charnsangavej C, et al. (2003) Multidetector-row helical CT and advanced postprocessing techniques for evaluation of pancreatic neoplasms. Abdom Imaging 28:366–377PubMedCrossRef Nino-Murcia M, Tamm EP, Charnsangavej C, et al. (2003) Multidetector-row helical CT and advanced postprocessing techniques for evaluation of pancreatic neoplasms. Abdom Imaging 28:366–377PubMedCrossRef
11.
go back to reference Lu DSK, Reber HA, Krasny RM, et al. (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR 168:1439–1443PubMed Lu DSK, Reber HA, Krasny RM, et al. (1997) Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR 168:1439–1443PubMed
12.
go back to reference Nakayama Y, Yamashita Y, Kadota M, et al. (2001) Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assisst Tomogr 25:337–342CrossRef Nakayama Y, Yamashita Y, Kadota M, et al. (2001) Vascular encasement by pancreatic cancer: correlation of CT findings with surgical and pathologic results. J Comput Assisst Tomogr 25:337–342CrossRef
13.
go back to reference Horton MK, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 1, evaluation of arterial involvement. AJR 178:827–831PubMed Horton MK, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 1, evaluation of arterial involvement. AJR 178:827–831PubMed
14.
go back to reference Jain S, Sacchi M, Vrachnos P, et al. (2005) Carcinoma of the pancreas with portal vein involvement—our experience with a modified technique of resection. Hepatogastroenterol 52(65):1596–600 Jain S, Sacchi M, Vrachnos P, et al. (2005) Carcinoma of the pancreas with portal vein involvement—our experience with a modified technique of resection. Hepatogastroenterol 52(65):1596–600
15.
go back to reference Li B, Chen FZ, Ge XH, et al. (2004) Pancreatoduodenectomy with vascuar reconstruction in treating carcinoma of the pancreatic head. Hepatobiliary Dis Int 3(4):612–615 Li B, Chen FZ, Ge XH, et al. (2004) Pancreatoduodenectomy with vascuar reconstruction in treating carcinoma of the pancreatic head. Hepatobiliary Dis Int 3(4):612–615
16.
go back to reference Shoup M, Winston C, Brennan MF, et al. (2004) Is there a role for staging laparoscopy in patients with locally advanced unresectable pancreatic adenocarcinoma? J Gastrointest Surg 8(8):1068–1071PubMedCrossRef Shoup M, Winston C, Brennan MF, et al. (2004) Is there a role for staging laparoscopy in patients with locally advanced unresectable pancreatic adenocarcinoma? J Gastrointest Surg 8(8):1068–1071PubMedCrossRef
Metadata
Title
Resectability of pancreatic adenocarcinoma: assessment using multidetector-row computed tomography with multiplanar reformations
Authors
Elena Manak
Susanne Merkel
Peter Klein
Thomas Papadopoulos
Werner A. Bautz
Ulrich Baum
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2009
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-007-9285-2

Other articles of this Issue 1/2009

Abdominal Radiology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.